Literature DB >> 7031934

Adjuvant immunotherapy or chemotherapy for malignant melanoma. Preliminary report of the National Cancer Institute randomized clinical trial.

R I Fisher, W D Terry, R J Hodes, S A Rosenberg, R Makuch, H G Gordon, S G Fisher.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 7031934     DOI： 10.1016/s0039-6109(16)42582-x

Source DB:  PubMed          Journal:  Surg Clin North Am        ISSN： 0039-6109            Impact factor:   2.741


× No keyword cloud information.
  11 in total

Review 1.  Preventing relapse in melanoma.

Authors:  J Stebbing; M Gore
Journal:  Curr Oncol Rep       Date:  2000-05       Impact factor: 5.075

Review 2.  Perianal melanoma disguised as hemorrhoids: case report and discussion.

Authors:  Vikisha T Fripp; Jesus Esquivel; Carlos A Cerruto
Journal:  J Natl Med Assoc       Date:  2005-05       Impact factor: 1.798

3.  A review of cancer chemotherapy for pet animals.

Authors:  A M Norris; S J Withrow
Journal:  Can Vet J       Date:  1984-04       Impact factor: 1.008

4.  The prognosis of melanoma patients with metastases to two or more lymph node areas.

Authors:  R J Barth; D J Venzon; A R Baker
Journal:  Ann Surg       Date:  1991-08       Impact factor: 12.969

Review 5.  Human adrenocortical carcinoma cell lines.

Authors:  Tao Wang; William E Rainey
Journal:  Mol Cell Endocrinol       Date:  2011-09-05       Impact factor: 4.102

Review 6.  Adjuvant Therapy for Melanoma.

Authors:  Aya Agha; Ahmad A Tarhini
Journal:  Curr Oncol Rep       Date:  2017-05       Impact factor: 5.075

7.  The significance of conversion of skin reactivity to efficacy of bacillus Calmette-Guérin (BCG) vaccinations given immediately after radical surgery in stage II melanoma patients.

Authors:  N Cascinelli; P Rümke; R MacKie; A Morabito; R Bufalino
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968

Review 8.  Current treatment options for malignant melanoma.

Authors:  G L Cohen; C I Falkson
Journal:  Drugs       Date:  1998-06       Impact factor: 9.546

Review 9.  Intratumoural administration and tumour tissue targeting of cancer immunotherapies.

Authors:  Ignacio Melero; Eduardo Castanon; Maite Alvarez; Stephane Champiat; Aurelien Marabelle
Journal:  Nat Rev Clin Oncol       Date:  2021-05-18       Impact factor: 66.675

10.  Adjuvant therapy: melanoma.

Authors:  Diwakar Davar; Ahmad Tarhini; John M Kirkwood
Journal:  J Skin Cancer       Date:  2011-12-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.